mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
5e-11 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
3e-08 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
3e-08 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
4e-08 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
6e-08 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
7e-08 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-07 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
2e-07 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-07 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
3e-07 |